-+ 0.00%
-+ 0.00%
-+ 0.00%

CNS Pharmaceuticals to Pursue Acquisition and In-Licensing of Neurology and Oncology Assets, While Exploring Out-Licensing of Berubicin and TPI 287 to Build a New Pipeline

Reuters·03/11/2026 12:35:15

Please log in to view news